This inventor holds 2 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Mesoblast International Sarl, Osiris Therapeutics, Inc.. Active years: 2013-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2023
Title: **Innovative Mind: The Contributions of Simon Bubnic**
Introduction
Simon Bubnic, based in Ann Arbor, Michigan, is a notable inventor whose work has made significant contributions to the field of regenerative medicine. With a focus on mesenchymal stem cells, his innovations aim to tackle critical medical challenges, particularly in immunology and transplantation.
Latest Patents
Simon holds two patents, both centered around mesenchymal stem cells that express TNF-alpha receptors. The first patent details mesenchymal stem cells which express TNF-alpha receptor Type I at an amount of at least 13 pg/10 cells. These specialized cells have the potential to inhibit lymphocyte proliferation, offering promising applications in treating graft-versus-host disease. The second patent reiterates the same innovative approach, highlighting the critical role of TNF-alpha receptor expression in developing novel therapeutic strategies.
Career Highlights
Throughout his career, Simon has collaborated with leading organizations in the biotech industry. He has played a pivotal role at Osiris Therapeutics, Inc., and Mesoblast International Sàrl, furthering the research and development of regenerative therapies. His work has been integral in bridging the gap between scientific research and clinical applications, leading to advancements that benefit patients in need of innovative treatment options.
Collaborations
Simon has worked alongside talented researchers including Alla Danilkovitch and Diane Carter. Their collaborative efforts have been instrumental in advancing their shared goals in the field of cellular therapies, enhancing the potential to treat complex medical conditions effectively.
Conclusion
In summary, Simon Bubnic is an influential inventor whose patents and projects have had a meaningful impact on the field of regenerative medicine. With his ongoing commitment to innovation and collaboration, he continues to contribute to the future of medical science, providing hope for patients and advancements in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile